| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Sep 02, 2021 | Sale | $27.26 | 34,000 | 926,943 | 20,750 | Sep 07, 2021, 07:17 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 29, 2021 | Option Exercise | $21.09 | 6,590 | 138,992 | 7,045 | Apr 30, 2021, 06:24 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 08, 2021 | Option Exercise | $20.94 | 400 | 8,378 | 3,950 | Apr 15, 2021, 07:12 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 07, 2021 | Sale | $20.99 | 1,656 | 34,753 | 4,578 | Apr 09, 2021, 05:53 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Sep 29, 2020 | Buy | $19.00 | 3,750 | 71,250 | 3,750 | Sep 29, 2020, 08:07 PM |
Menu